![Gregory Demopulos](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gregory Demopulos
Directeur Général chez
OMEROS CORPORATION
Fortune : 16 M $ au 31/05/2026
Profil
Gregory A. Demopulos is the founder of Omeros Corp., founded in 1994, where the title held is Chairman, President & Chief Executive Officer since 2013.
Current jobs include Director at Onconome, Inc., Director at Tessera, Inc., Director at Northwest NeuroNeighborhood, and Trustee at Smead Funds Trust.
Education history includes undergraduate studies at Stanford University and a doctorate from Stanford University School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
OMEROS CORPORATION 2,03 % | 17/04/2026 | 1 469 308 ( 2,03 % ) | 16 M $ | 31/05/2026 |
Postes actifs de Gregory Demopulos
| Sociétés | Poste | Début |
|---|---|---|
| OMEROS CORPORATION | Directeur Général | 16/06/1994 |
Tessera, Inc.
 Tessera, Inc. SemiconductorsElectronic Technology Provides packaging solutions for the semiconductor industry | Directeur/Membre du Conseil | - |
Onconome, Inc.
 Onconome, Inc. Medical SpecialtiesHealth Technology Provides development and commercialization of innovative biomarkers | Directeur/Membre du Conseil | - |
Smead Funds Trust
 Smead Funds Trust Investment Trusts/Mutual FundsMiscellaneous Acts as Open-End Investment Fund/Unit Trust | Directeur/Membre du Conseil | - |
Northwest NeuroNeighborhood | Directeur/Membre du Conseil | - |
Formation de Gregory Demopulos
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
40
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Omeros Corp.
 Omeros Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes small-molecule & protein therapeutics | Health Technology |
Onconome, Inc.
Onconome, Inc. Medical SpecialtiesHealth Technology Provides development and commercialization of innovative biomarkers | Health Technology |
Smead Funds Trust
Smead Funds Trust Investment Trusts/Mutual FundsMiscellaneous Acts as Open-End Investment Fund/Unit Trust | Miscellaneous |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tessera, Inc.
Tessera, Inc. SemiconductorsElectronic Technology Provides packaging solutions for the semiconductor industry | Electronic Technology |
Stanford University School of Medicine
 Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northwest NeuroNeighborhood |
Choisissez Zonebourse 
